Heparin neutralization with platelet factor 4 fragments
US5482923A · kind A · utility
3Cited by
4References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 16, 1993 |
| Grant date | Jan 9, 1996 |
| Priority date | — |
| Expiry date | Apr 16, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/195
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Circulating heparin in a mammal may be neutralized without substantial depletion of platelets or leukocytes by administering to the mammal a heparin neutralizing amount of a purified heparin binding fragment of PF4 or of recombinant PF4.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.